Highlights of three metabolites HDL and reduction in blood pressure values after dietary fiber supplementation in overweight and obese normotensive women: a metabolomic study
-
Published:2023-11-17
Issue:12
Volume:19
Page:
-
ISSN:1573-3890
-
Container-title:Metabolomics
-
language:en
-
Short-container-title:Metabolomics
Author:
da Silva Cássia Surama Oliveira,Monteiro Mussara Gomes Cavalcanti Alves,Fechine Carla Patricia Novaes dos Santos,Tavares Josean Fechine,Souto Augusto Lopes,Luna Rafaella Cristhine Pordeus,Pimenta Flávia Cristina Fernandes,e Silva Ana Herminia Andrade,da Silva Diniz Alcides,da Silva Júnior Celso Costa,Alverga Caio César Ferreira,dos Santos Sócrates Golzio,Persuhn Darlene Camati,de Carvalho Costa Maria José
Abstract
Abstract
Introduction
The prevalence of hypertension and obesity are a worldwide concern.
Objetives
Assess the metabolites profile after intervention with mixed dietary fiber in overweight and obese normotensive women.
Methods
This is a randomized double blind placebo-controlled study. Through a simple randomization process, two groups were allocated, with eleven women (group 1) receiving 12 g of mixed dietary fiber and thirteen women (group 2) receiving 12 g of placebo (corn starch) for eight weeks. Anthropometric and biochemical tests and lifestyle were analyzed. As for evaluation metabolomics, used a 1H NMR. The data matrix generated 96 samples and 225 variables, which was exported in the ASCII format for the “The Unscrumbler” statistics software (version 9.7, CAMO Process).
Results
After the intervention with mixed dietary fiber, significant differences were observed between the main types of metabolites, referring to the increase in the relative peak areas of in three HDL metabolites 4.94 ppm (0.0086*), HDL 1.28 ppm (0 .0337*), HDL 0.88 ppm (0.0224*) and an α-glucose metabolite 4.90 ppm (0.0106) and the reduction in systolic blood pressure (SBP) (0.0292*) of 7 mmHg in the reference range and in the placebo group there was a reduction in SBP (0.0118*) of 4 mmHg and of a choline metabolite 3.65 ppm (0.0266*), which does not call into question the validity of these results in the literature.
Conclusion
The synergism of the functions of these statistically highlighted metabolites contributed to prevention the increase in SBP after fiber intervention in overweight and obese normotensive women.
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference59 articles.
1. Akiyama, M., Mizokami, T., Ito, H., & Ikeda, Y. (2023). A randomized, placebo-controlled trial evaluating the safety of excessive administration of kaempferol aglycone. Food Sci Nutr, 11(9), 5427–5437. https://doi.org/10.1002/fsn3.3499. 2. Allain, C. C., Poon, L. S., Chan, C. S., Richmond, W., & Fu, P. C. (1974). Enzymatic determination of total serum cholesterol. Clinical chemistry, 20(4), 470–475. 3. American Diabetes Association. (2017). 1. Promoting Health and Reducing Disparities in Populations. Diabetes Care, 40(Supplement_1), S6–S10. https://doi.org/10.2337/dc17-S004. 4. Amin, M. T., Fatema, K., Arefin, S., Hussain, F., Bhowmik, D. R., & Hossain, M. S. (2021). Obesity, a major risk factor for immunity and severe outcomes of COVID-19. Bioscience Reports, 41(8), BSR20210979. https://doi.org/10.1042/BSR20210979. 5. Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., & Ziaeian, B. (2019). 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 140(11), e563–e595.
|
|